| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 89.39B | 88.78B | 81.78B | 72.11B | 57.60B | 56.75B |
| Gross Profit | 20.80B | 20.90B | 17.01B | 14.61B | 13.28B | 11.03B |
| EBITDA | 9.96B | 10.71B | 9.48B | 6.85B | 5.66B | 4.19B |
| Net Income | 5.57B | 5.72B | 5.15B | 2.95B | 1.97B | 712.07M |
Balance Sheet | ||||||
| Total Assets | 96.63B | 96.71B | 101.43B | 95.38B | 89.27B | 80.38B |
| Cash, Cash Equivalents and Short-Term Investments | 24.82B | 21.52B | 29.62B | 26.63B | 27.15B | 20.33B |
| Total Debt | 14.15B | 14.35B | 12.39B | 13.60B | 14.89B | 14.18B |
| Total Liabilities | 52.87B | 52.50B | 50.58B | 49.65B | 46.20B | 39.17B |
| Stockholders Equity | 43.70B | 44.15B | 50.79B | 45.68B | 43.03B | 41.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.03B | 2.05B | 1.28B | 6.43B | 1.13B |
| Operating Cash Flow | 0.00 | 9.35B | 4.67B | 4.49B | 7.87B | 3.04B |
| Investing Cash Flow | 0.00 | -6.51B | 450.66M | -3.08B | -1.30B | -1.85B |
| Financing Cash Flow | 0.00 | -10.80B | -2.10B | -1.98B | 84.35M | -2.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥72.32B | 9.50 | ― | 2.63% | -6.00% | -13.74% | |
75 Outperform | ¥114.59B | 19.34 | ― | 0.55% | 9.04% | -7.84% | |
73 Outperform | ¥19.01B | 20.01 | ― | 2.78% | 38.48% | 100.84% | |
71 Outperform | ¥56.82B | 10.14 | 11.47% | 1.88% | -0.04% | 15.59% | |
70 Outperform | ¥141.76B | 7.70 | 8.17% | 2.04% | 1.48% | 58.59% | |
70 Outperform | ¥69.96B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |